This year’s GIANT has launched a new conference track to explore how the future of health tech can be financed. Through discussion with the companies tackling today’s health moonshots, and the visionary investors financing them, we will look at how innovation can be accelerated. Bringing together the investment community with start-ups, scale-ups and innovators from across Europe and around the world we will talk about trends, products and business models and provide a productive space for meeting and collaborating.
Why attend?
• The future of health tech innovation depends on visionary entrepreneurs having the resources available to build great
products and great companies.
•Ageing, growing populations, and the increase in chronic illnesses such as obesity and diabetes are not small problems.
They demand efficient new solutions, built in a strong ecosystem, prepared to take some calculated risk.
• Health moonshots require radical collaboration around audacious health goals; we are bringing together investors, startups
and corporate innovators, with the right mindset, a moonshot vision to speed up progress in solving big health challenges,
ensuring access to care and improving the wellbeing of people worldwide
Capital planning in healthcare is not merely an administrative obligation—it is a strategic discipline that shapes clinical capabilities, operational resilience and financial health.
Recognising and addressing common planning mistakes is essential to sustaining high-quality, efficient care in an increasingly complex…
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of…